Answer
Rivastigmine inhibits acetylcholinesterase and butyrylcholinesterase by forming covalently bound complexes that temporarily inactivate these enzymes, and is thought to enhance cholinergic neurotransmission by slowing degradation of acetylcholine released by functionally intact cholinergic neurones.
Sources for this answer
- Exelon 4.6 mg/24h, 9.5 mg/24h, 13.3 mg/24h transdermal patchNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 21Document updated
Sources checked